首页> 外文期刊>The Lancet infectious diseases >Symptomatic hyperlactataemia precipitated by the addition of tetracycline to combination antiretroviral therapy.
【24h】

Symptomatic hyperlactataemia precipitated by the addition of tetracycline to combination antiretroviral therapy.

机译:在联合抗逆转录病毒治疗中加入四环素可引起症状性高乳酸血症。

获取原文
获取原文并翻译 | 示例
           

摘要

Hyperlactataemia in the setting of combination antiretroviral therapy for HIV infection occurs on a spectrum ranging from common, asymptomatic laboratory abnormalities to rare, potentially life-threatening lactic acidosis. Some other medications, including the biguanides, tetracycline, and even linezolid, have rarely been reported to cause lactic acidosis. Recently, cases of lactic acidosis or hyperlactataemia have been reported in patients receiving combination antiretroviral therapy that have been precipitated by the addition of other medications-eg, metformin or ribavirin. We report a case of symptomatic hyperlactataemia in a patient on combination antiretroviral therapy that was likely precipitated by the addition of tetracycline and discuss the broader implications of other medications with the potential to cause hyperlactataemia in the setting of combination antiretroviral therapy.
机译:联合抗逆转录病毒疗法治疗HIV感染时的高乳酸血症发生范围从常见的无症状实验室异常到罕见的,可能危及生命的乳酸酸中毒。很少有其他药物,包括双胍类,四环素,甚至利奈唑胺类药物,引起乳酸性酸中毒。近来,已经报道了接受联合抗逆转录病毒疗法的患者发生乳酸性酸中毒或高乳酸血症的病例,这些患者通过添加其他药物(如二甲双胍或利巴韦林)而沉淀。我们报告了一名患者在联合抗逆转录病毒治疗中出现症状性高乳酸血症的情况,该患者可能因添加四环素而沉淀,并讨论了在联合抗逆转录病毒治疗中可能引起高乳酸血症的其他药物的更广泛影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号